Trade XBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Xenetic Biosciences, Inc. (XBIO) is trading at US$2.90, up 4.55% today as of Sep 21, 14:50 EDT. The company has a market capitalisation of US$8.41M. Over the past 52 weeks, XBIO has traded between US$1.87 and US$13.93. On Syfe you can trade XBIO with $0 commission and add it to your watchlist.
| Previous close | US$2.77 |
|---|---|
| Market cap | US$8.41M |
| 52-week range | US$1.87 – US$13.93 |
| Volume | 415.01K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
Year: 2012
Xenetic Biosciences, Inc. (XBIO) stock is trading at US$2.90, +4.55% from the previous close of US$2.77.
The market cap for Xenetic Biosciences, Inc. (XBIO) stock is approximately US$8.41M.
The 52-week high for Xenetic Biosciences, Inc. (XBIO) stock is US$13.93.
The 52-week low for Xenetic Biosciences, Inc. (XBIO) stock is US$1.87.
Xenetic Biosciences, Inc. (XBIO) does not currently pay a dividend.
Stay on top of XBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
